Annual report pursuant to Section 13 and 15(d)

Stockholders' Deficit (Details Narrative)

v3.19.3
Stockholders' Deficit (Details Narrative) - USD ($)
8 Months Ended 12 Months Ended
Sep. 19, 2019
Nov. 05, 2018
Jul. 23, 2018
Jul. 20, 2018
Jun. 28, 2018
Sep. 27, 2017
Sep. 21, 2017
Aug. 14, 2017
Feb. 07, 2017
Sep. 10, 2019
Dec. 31, 2018
Dec. 31, 2017
Sep. 18, 2018
May 09, 2018
Common stock par value                     $ 0.0001 $ 0.0001 $ 0.0001  
Common stock shares authorized                     10,000,000,000 10,000,000,000 10,000,000,000  
Preferred stock shares authorized                     5,000,000   5,000,000  
Preferred stock par value                     $ 0.01   $ 0.01  
Conversion of stock into shares                     20,000,000      
Number of common stock issued on conversion                     $ 8,128,044 $ 7,306,314    
Number of common stock issued, valuie                     $ 4,619,150      
Common stock shares issued                     128,567,273 39,502    
Common stock shares outstanding                     128,567,273 39,502    
Recognized stock stock-based compensation                     $ 285,992 $ 303,046    
Reserve stock split, description   1-for-500 reverse stock split         1-for-15 reverse stock split   1-for-30 reverse stock split          
2007 Equity Plan [Member]                            
Stock option expense                     $ 100,000 200,000    
Weighted average period                     7 years 3 months 19 days      
Intrinsic value of options exercisable                     $ 0 0    
Remaining stock option expense                     $ 34,600      
Subsequent Event [Member]                            
Number of shares converted                   7,380,369,502        
Common stock shares outstanding                   7,508,936,775        
Reserve stock split, description Specific ratio ranging up to 1-for-10,000                          
Restricted Stock [Member]                            
Recognized stock stock-based compensation                       189,209    
Employees and Directors [Member]                            
Number of restricted stock issued               364            
Recognized stock stock-based compensation                       $ 244,768    
Employees and Directors [Member] | Restricted Stock [Member]                            
Number of restricted stock issued                     142,667      
Recognized stock stock-based compensation                     $ 477,933      
Number of restricted stock shares forfeited                     122      
Stock issued price per share                     $ 3.35      
Common Stock [Member]                            
Common stock shares authorized                           3,000,000,000
Number of shares converted                     106,335,991      
Shares converted into debt                     4,221,601 36,571    
Number of common stock issued on conversion                     $ 422 $ 4    
Number of common stock issued                     17,788,579      
Number of common stock issued, valuie                     $ 1,779      
Number of restricted stock issued                     142,667 364    
Common Stock [Member] | March 2017 Debentures [Member]                            
Shares converted into debt                     4,221,601      
Number of common stock issued on conversion                     $ 6,700,000      
Common stock shares issued                     17,788,579      
Cashless exercise warrants                     106,006,177      
Warrants [Member]                            
Number of warrants isssued as anti-dilution provision                     53,234,923,889      
Minimum [Member]                            
Common stock par value                         0.0001  
Maximum [Member]                            
Common stock par value                         $ 0.01  
Series G Preferred Stock [Member]                            
Preferred stock shares authorized                     14,000 14,000    
Preferred stock par value                     $ 0.01 $ 0.01    
Preferred stock shares outstanding                     215 215    
Preferred stock, stated value                     $ 1,000      
Weighted average common stock price percentage                     85.00%      
Shares converted into debt                        
Number of common stock issued on conversion                        
Number of common stock issued                          
Number of common stock issued, valuie                          
Series H Preferred Stock [Member]                            
Preferred stock shares authorized                     14,202 14,202    
Preferred stock par value                     $ 0.01 $ 0.01    
Preferred stock shares outstanding                     10 60    
Preferred stock, stated value                     $ 1,000      
Weighted average common stock price percentage                     85.00%      
Number of preferred stock converted         50             7,785    
Conversion of stock into shares         40,000           50 742    
Number of shares converted                     40,000      
Shares converted into debt                       2,174    
Number of common stock issued on conversion                       $ 2,200,000    
Principal amount of debt converted into shares                       $ 2,700,000    
Series F Convertible Preferred Stock [Member]                            
Preferred stock shares outstanding                     1,750,000      
Series F Convertible Preferred Stock [Member] | Genomas, Inc [Member]                            
Conversion of stock into shares           120                
Number of common stock issued           1,750,000                
Number of common stock issued, valuie           $ 174,097                
Stock conversion share price           $ 14,625                
Preferred stock price per share for unpaid dividend           $ 1.95                
Series J Convertible Preferred Stock [Member]                            
Preferred stock shares outstanding                     250,000      
Number of common stock issued       250,000                    
Series J Convertible Preferred Stock [Member] | Alcimede LLC [Member]                            
Preferred stock, stated value     $ 1.00                      
Number of common stock issued     250,000                      
Number of common stock issued, valuie     $ 250,000                      
Preferred stock voting rights     Each share of the Series J Preferred Stock had the whole number of votes equal to 24 shares of common stock. With respect to all other matters, and from and after October 1, 2018, each share of the Series J Preferred Stock is entitled to the whole number of votes equal to the number of common shares into which it is then convertible.                      
Cumulative dividends percentage     8.00%                      
Series J Convertible Preferred Stock [Member] | Alcimede LLC [Member] | Minimum [Member]                            
Preferred stock shares authorized     3,000,000,000                      
Series J Convertible Preferred Stock [Member] | Alcimede LLC [Member] | Maximum [Member]                            
Preferred stock shares authorized     10,000,000,000                      
Series I-2 Preferred Stock [Member]                            
Number of shares converted                     106,335,991      
Number of common stock issued on conversion                     $ 1,500,000      
Series I-2 Preferred Stock [Member] | Common Stock [Member]                            
Conversion of stock into shares                     1,286.141      
Number of shares converted                     106,335,991